PAS
IMRX icon

Point72 Asia (Singapore)’s Immuneering IMRX Stock Holding History

Point72 Asia (Singapore)’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,421
Closed -$38.3K – 1036
2024
Q4 		$38.3K Sell
17,421
-403
-2% -$836 0.01% 553
2024
Q3 		$44.4K Sell
17,824
-16,785
-48% -$24.4K 0.01% 712
2024
Q2 		$44.3K Buy
+34,609
New +$56.9K 0.01% 691

Other funds holding IMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asia (Singapore)'s IMRX Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of Immuneering (IMRX) in Q1 2025, closing a stake of 17,421 shares — an estimated $38.3K sold.

Point72 Asia (Singapore) first reported a position in IMRX in Q2 2024 and held it in 3 quarters. The position peaked at $44.4K in Q3 2024. 35 funds tracked by Wall St. Rank hold IMRX as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining Immuneering position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 17,421 Immuneering shares in Q1 2025, an estimated $38.3K.
  • Point72 Asia (Singapore) first reported a position in Immuneering in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Immuneering position peaked at $44.4K in Q3 2024.
  • 35 funds tracked by Wall St. Rank held Immuneering as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.